342 related articles for article (PubMed ID: 28840583)
21. Effects of granulocyte-colony stimulating factor (G-CSF) on stem cell mobilization in patients with liver failure.
Engelmann C; Splith K; Berg T; Schmelzle M
Eur J Intern Med; 2016 Dec; 36():e37-e39. PubMed ID: 27745994
[No Abstract] [Full Text] [Related]
22. Risk Factors and Outcomes of Acute Kidney Injury in Patients With Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.
Yuan W; Zhang YY; Zhang ZG; Zou Y; Lu HZ; Qian ZP
Am J Med Sci; 2017 May; 353(5):452-458. PubMed ID: 28502331
[TBL] [Abstract][Full Text] [Related]
23. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.
Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA
Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869
[TBL] [Abstract][Full Text] [Related]
24. Multiple Cycles of Granulocyte Colony-Stimulating Factor Increase Survival Times of Patients With Decompensated Cirrhosis in a Randomized Trial.
De A; Kumari S; Singh A; Kaur A; Sharma R; Bhalla A; Sharma N; Kalra N; Singh V
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):375-383.e5. PubMed ID: 32088302
[TBL] [Abstract][Full Text] [Related]
25. The efficacy and safety of granulocyte colony-stimulating factor in the treatment of acute-on-chronic liver failure: A systematic review and meta-analysis.
Qiu B; Liang JX; Romero Gómez M
PLoS One; 2023; 18(11):e0294818. PubMed ID: 38033111
[TBL] [Abstract][Full Text] [Related]
26. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.
Garg H; Sarin SK; Kumar M; Garg V; Sharma BC; Kumar A
Hepatology; 2011 Mar; 53(3):774-80. PubMed ID: 21294143
[TBL] [Abstract][Full Text] [Related]
27. Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF.
Engelmann C; Habtesion A; Hassan M; Kerbert AJ; Hammerich L; Novelli S; Fidaleo M; Philips A; Davies N; Ferreira-Gonzalez S; Forbes SJ; Berg T; Andreola F; Jalan R
J Hepatol; 2022 Nov; 77(5):1325-1338. PubMed ID: 35843375
[TBL] [Abstract][Full Text] [Related]
28. Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study.
Cárdenas A; Solà E; Rodríguez E; Barreto R; Graupera I; Pavesi M; Saliba F; Welzel TM; Martinez-Gonzalez J; Gustot T; Bernardi M; Arroyo V; Ginès P;
Crit Care; 2014 Dec; 18(6):700. PubMed ID: 25643318
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of Granulocyte Colony-Stimulating Factor in Acute on Chronic Liver Failure: A Systematic Review and Survival Meta-Analysis.
Konstantis G; Tsaousi G; Pourzitaki C; Kitsikidou E; Magouliotis DE; Wiener S; Zeller AC; Willuweit K; Schmidt HH; Rashidi-Alavijeh J
J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892679
[TBL] [Abstract][Full Text] [Related]
30. Acute-On-Chronic Liver Failure: Causes, Clinical Characteristics and Predictors of Mortality.
Tasneem AA; Luck NH
J Coll Physicians Surg Pak; 2017 Jan; 27(1):8-12. PubMed ID: 28292360
[TBL] [Abstract][Full Text] [Related]
31. Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure.
Khanam A; Trehanpati N; Garg V; Kumar C; Garg H; Sharma BC; Sarin SK
Liver Int; 2014 Apr; 34(4):505-13. PubMed ID: 24754047
[TBL] [Abstract][Full Text] [Related]
32. Improving survival in ACLF: growing evidence for use of G-CSF.
Simonetto DA; Shah VH; Kamath PS
Hepatol Int; 2017 Nov; 11(6):473-475. PubMed ID: 29124667
[No Abstract] [Full Text] [Related]
33. Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure.
Li Q; Lu Q; Zhu MQ; Huang C; Yu KK; Huang YX; Zhao X; Luo XG; Zheng JM
BMC Gastroenterol; 2020 Apr; 20(1):106. PubMed ID: 32293297
[TBL] [Abstract][Full Text] [Related]
34. External validation and comparison of six prognostic models in a prospective cohort of HBV-ACLF in China.
Shen Y; Liu YM; Wang B; Zhu YG; Wang YY; Wang XL; Ji JL; Shao JG; Qin Y; Qin G
Ann Hepatol; 2016; 15(2):236-45. PubMed ID: 26845601
[TBL] [Abstract][Full Text] [Related]
35. Multiple cycles of granulocyte colony-stimulating factor in decompensated cirrhosis: a double-blind RCT.
Venkitaraman A; De A; Verma N; Kumari S; Leishangthem B; Sharma RR; Kalra N; Grover S; Singh V
Hepatol Int; 2022 Oct; 16(5):1127-1136. PubMed ID: 35322373
[TBL] [Abstract][Full Text] [Related]
36. The Transforming Growth Factor β1/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and Survival.
Yu X; Guo R; Ming D; Deng Y; Su M; Lin C; Li J; Lin Z; Su Z
Clin Vaccine Immunol; 2015 May; 22(5):484-92. PubMed ID: 25716231
[TBL] [Abstract][Full Text] [Related]
37. Elevated mean platelet volume is associated with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients.
Han L; Han T; Nie C; Zhang Q; Cai J
Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):331-9. PubMed ID: 25465870
[TBL] [Abstract][Full Text] [Related]
38. Combined glucocorticoid and antiviral therapy of hepatitis B virus-related liver failure.
Bockmann JH; Dandri M; Lüth S; Pannicke N; Lohse AW
World J Gastroenterol; 2015 Feb; 21(7):2214-9. PubMed ID: 25717260
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure.
Shi X; Zhu P; Yan G; Liu C; Zhang C; Huang G; Zhang Y; Yan Z; Wang Y
J Viral Hepat; 2016 Nov; 23(11):920-929. PubMed ID: 27397610
[TBL] [Abstract][Full Text] [Related]
40. Serum levels of miRNA in patients with hepatitis B virus-associated acute-on-chronic liver failure.
Wen Y; Peng SF; Fu L; Fu XY; Wu DX; Liu BJ; Tan DM; Ouyang Y
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):126-132. PubMed ID: 29602672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
